A solution of the enzyme glycogen synthase incubated at 45°C lost 70% of its activity in 3 minutes„but when incubated at 45°C in the presence of a very large concentration of its substrate UDP-Glucose, it lost only 3% of its activity in the same amount of time, Why?CluCH,OHCH, OHHO,онCH;OHCH2OHноHOонHOUDPO-P-0OHOHNHo--oCH, OHCH2OHCH,OHOH OHHOUDP-glucose binding makes it easier for the enzyme to unfold.The enzyme likely had phosphate groups added through covalent modification.O Interactions with the bound UDP-glucose stabilize the tertiary structure of glycogen synthase.The UDP-Glucose is a positíve effector which increases the enzyme activity.

The enzyme loses its activity indicates that the tertiary structure (functional structure) of the…

A solution of the enzyme glycogen synthase incubated at 45°C lost 70% of its activity in 3 minutes but when incubated at 45°C in the presence of a very large concentration of its substrate UDP- Glucose, it lost only 3% of its activity in the same amount of time, Why? CH OH CH, OH CH,OH CH,OH HO HO, HO UDP O-0 OH OH NH 5,5,5 CH, OH CHOH CH,OH он он Он он HO UDP-glucose binding makes it easier for the enzyme to unfold. The enzyme likely had phosphate groups added through covalent modification. Interactions with the bound UDP-glucose stabilize the tertiary structure of glycogen synthase. The UDP-Glucose is a positive effector which increases the enzyme activity.

A solution of the enzyme glycogen synthase incubated at 45°C lost 70% of its activity in 3 minutes but when incubated at 45°C in the presence of a very large concentration of its substrate UDP- Glucose, it lost only 3% of its activity in the same amount of time, Why? CH OH CH, OH CH,OH CH,OH HO HO, HO UDP O-0 OH OH NH 5,5,5 CH, OH CHOH CH,OH он он Он он HO UDP-glucose binding makes it easier for the enzyme to unfold. The enzyme likely had phosphate groups added through covalent modification. Interactions with the bound UDP-glucose stabilize the tertiary structure of glycogen synthase. The UDP-Glucose is a positive effector which increases the enzyme activity.

Chemistry

10th Edition

ISBN:9781305957404

Author:Steven S. Zumdahl, Susan A. Zumdahl, Donald J. DeCoste

Publisher:Steven S. Zumdahl, Susan A. Zumdahl, Donald J. DeCoste

Chapter1: Chemical Foundations

Section: Chapter Questions

Problem 1RQ: Define and explain the differences between the following terms. a. law and theory b. theory and...

See similar textbooks

Similar questions

Use the name of the enzyme and any coenzyme to predict the products of this reaction. 0 OH NAD 2- LOPO, glyceraldehyde 3-phosphate dehydrogenase
The interaction of F16BP with pyruvate kinase (PK) is an example of O product inhibition. feed-forward activation. feed-back inhibition. competitive activation.
1. Examine the following pair of reactions. What type of enzyme would catalyze each of these reactions? Select the single best answer. C-H H-C-OH HO-C-H H-C-OH H-C-OH H-C-H O -O-P-O O O O O O O enolases isomerases aldolases nucleases mutases kinases CH₂OH C=O HO-C-H H-C-OH H-C-OH H-C-H O -O-P-O ܘܐܘܐܐܐ CH₂OH H-C-H O-P-O O C-H H-C-OH H-C-H O O-P-O
Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and gout, several medications are used to inhibit the activity of xanthine oxidase and reduce the production of uric acid. You are a biochemist and just discovered a chemical that can inhibit the activity of the human xanthine oxidase. When analyzing its mode of inhibition, you found that the enzyme inhibitor complex requires 450 J.mol-1 to dissociate and that it displays kinetics somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministry of health for approval as a medication for gout. Based on the data provided, are they going to authorize it as a medication or not? Explain?
GR Methanol and ethanol bind to the same active site on the enzyme alcohol dehydrogenase (ADH) to undergo oxidation, as shown in the equations below. In methanol poisoning, ethanol is given intravenously to prevent the formation of formaldehyde that has toxic effects. In this scenario, what type of inhibitor is ethanol with regard to alcohol dehydrogenase catalyzing the oxidation of methanol? budy CH3-OH + NAD+ HCHO+NADH + H+ CH3-CH2-OH + NAD+ CH3-CHO + NADH + H* O a competitive inhibitor ADH O an irreversible inhibitor ADH O a noncompetitive inhibitor O both a noncompetitive and an irreversible inhibitor O Sea hp
Assume that in a certain cell, the ratio of products/reactants or Keq = 614.9 (Keq is dimensionless) for the reaction Glucose + ATP <> Glucose-6-P + ADP, at a particular instant, the concentrations of each compound were Glucose =4.3M, ATP =10.5M, ADP =17.3M and G-6-P =23.5M. Calculate the difference (dimensionless) between Keq and the ratio of products/ractants at this instance, in this cell, to five significant figures.
CH₂OH T C=O CH₂OPO²- DHAP Triose phosphate isomerase H HCOH CH₂OPO3²- G-3-P Under standard conditions, AG° = +7.53 kJ/mol. What is AG when the initial concentration of DHAP is 2 x 10-4 M and the initial concentration of G-3-P is 3 x 10-6 M? R = 8.314 x 10-3 kJ*mol-¹*K-1 T = 310 K
Identify the most likely additional substrates, products, and coenzymes for each reaction in the following imaginary pathway.
Identify each given example as describing either a glycolysis intermediate or another compound. Glycolysis intermediate Other compound fructose COO™ c-o- -POS || CH₂ HO CH₂ OH OH Answer Bank a five-carbon phosphorylated compound H-C=O H-C-OH H-C-O-PO H -²0₂PO. CH₂ OH H₂C-OPO OH 2-
Although the ATP-ADP reaction is the principle energy shuttle in metabolic pathways, many other examples of coupled reactions exist. glutamic acid + NH3 glutamine + H2O, ΔGo = 14 kJ. Can be coupled with the acetyl phosphate reaction shown CH3COOPO3H2 + H2O CH3COOH + H3PO4, ΔGo = -46.9 kJ a. Calculate ΔGo for the overall process.
1. Identify the most likely additional substrates, products, and coen- zymes for each reaction in the following imaginary pathway. COO Н—с—NH— сно CoO COO CH, Н—с—NH—сно H-C-NH3 CH2 CH2 CH2 CH2 H-C-CH3 H-C-CH3 H-C-NH, H-C-NH3 H-C-NH3 COO COO || C-NH2 || C-NH2 C- NH2 H-C-NH3 H-C-NH3 H-C-NH-CH3 CH2 CH2 CH2 H-C-CH3 H-C-CH3 H-C-CH3 H-C- NH3 C=0 C=0 CoO CoO COO -0- O=0- -
1